Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 63,400 shares of the stock in a transaction that occurred on Friday, April 11th. The stock was purchased at an average cost of $8.81 per share, with a total value of $558,554.00. Following the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,509,875. Opko Health Inc. (NYSE:OPK) shares after opening at $8.97 moved to $8.98 on last trade day and at the end of the day closed at $8.37. Company price to sales ratio in past twelve months was calculated as 35.81 and price to cash ratio as 18.60. Opko Health Inc. (NYSE:OPK) showed a negative weekly performance of -9.42%.
Glaxosmithkline PLC (ADR) (NYSE:GSK) on Thursday said senior executives, including Chief Executive Andrew Witty and Chief Financial Officer Simon Dingermans, acquired shares under the company share reward plan at a price of 1572.79 pence Wednesday. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares advanced 0.15% in last trading session and ended the day on $51.84. GSK return on equity ratio is recorded as 114.20% and its return on assets is 17.70%. GlaxoSmithKline plc (ADR) (NYSE:GSK) yearly performance is 10.34%.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Director Bruce Kovner bought 1,250,000 shares of the company’s stock in a transaction that occurred on Friday, April 11th. The stock was purchased at an average cost of $4.01 per share, for a total transaction of $5,012,500.00. Following the completion of the transaction, the director now directly owns 3,048,666 shares in the company, valued at approximately $12,225,151. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) shares moved up 2.00% in last trading session and was closed at $4.09, while trading in range of $3.97 – $4.18. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) year to date (YTD) performance is -21.95%.
Spherix Inc. (NASDAQ:SPEX)’s CEO Anthony Hayes buy 4000 shares of SPEX in a transaction dated on April 11, 2014. Spherix Inc. (NASDAQ:SPEX) shares were bought at an average price of $2.35 for total worth of $9,400.00. Spherix Inc. (NASDAQ:SPEX) weekly performance is -14.58%. On last trading day company shares ended up $2.05. Spherix Inc. (NASDAQ:SPEX) distance from 50-day simple moving average (SMA50) is -53.05%. Analysts mean target price for the company is $1.00.
Leave a Reply